Clinical and Molecular Features of Patients With Congenital Disorders of Glycosylation in Japan

Documents similaires

• Treatment of Single Patient With PMM2 ‐Congenital Disorder of Glycosylation With Govorestat ( AT ‐007), an Aldose Reductase Inhibitor
  par: Elizabeth R. Jalazo, et autres
  Publié: (2025)
• A Mild Juvenile Onset Canavan Disease With Atypical Clinical Presentation and MRI Brain Features
  par: Preeya Rehsi, et autres
  Publié: (2025)
• Correction to “Expanding the Genetic and Clinical Spectrum of SLC25A42 Associated Disorders and Testing of Pantothenic Acid to Improve CoA Level In Vitro”
  Publié: (2025)
• Severe Neurological Presentation in Siblings With COQ5 ‐Related Primary Coenzyme Q10 Deficiency: Expanding Clinical and Molecular Spectrum
  par: Parith Wongkittichote, et autres
  Publié: (2025)
• Treatment Beliefs Reflect Unmet Clinical Needs in Lysosomal Storage Diseases: An Opportunity for a Patient‐Centered Approach
  par: Eleonore M. Corazolla, et autres
  Publié: (2025)